Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial Results And Conference Call

 Avanir Pharmaceuticals Announces Date Of Fiscal 2013 First Quarter Financial
                         Results And Conference Call

PR Newswire

ALISO VIEJO, Calif., Jan. 30, 2013

ALISO VIEJO, Calif., Jan.30, 2013 /PRNewswire/ --Avanir Pharmaceuticals,
Inc. (NASDAQ: AVNR) will report financial results for the quarter ended
December 31, 2012 after market close on Thursday February 7, 2013. The company
will conduct a conference call and an audio webcast at 1:30 pm Pacific Time
(4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1 (866) 783-2141
International callers: +1 (857) 350-1600
Passcode: 51423033

Webcast information: Visit http://www.avanir.com.

A webcast replay will be available on the Avanir Web site for 30 days. A
telephone replay will be available for 48 hours following the conclusion of
the call by dialing 1 (888) 286-8010 for domestic callers, or +1 (617)
801-6888 for international callers, and entering reservation code 87153907.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on
bringing innovative medicines to patients with central nervous system
disorders of high unmet medical need. As part of our commitment, we have
extensively invested in our pipeline and are dedicated to advancing medicines
that can substantially improve the lives of patients and their loved ones. For
more information about Avanir, please visit www.avanir.com.

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

SOURCE Avanir Pharmaceuticals, Inc.

Website: http://http://www.avanir.com
Contact: Avanir Investors & Media - Ian Clements, PhD, ir@avanir.com,
+1-949-389-6700